BCL2 is commonly overexpressed in prostate cancer compared to normal prostate [40] and elevation of BCL2 expression is associated with poor prognosis and suspected in the development of castration-resistant prostate cancer [41–43]. Here, BCL2 is linked to prostate carcinoma.